Seoul Pharma Co., Ltd (KOSDAQ:018680)
South Korea · Delayed Price · Currency is KRW 2,650.00
-30.00 (-1.12%)
At close: Mar 31, 2026
Seoul Pharma Revenue
In the year 2025, Seoul Pharma had annual revenue of 52.15B KRW, down -2.67%. Seoul Pharma had revenue of 13.61B in the quarter ending December 31, 2025, a decrease of -2.05%.
Revenue
52.15B
Revenue Growth
-2.67%
P/S Ratio
0.59
Revenue / Employee
303.19M
Employees
172
Market Cap
30.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 52.15B | -1.43B | -2.67% |
| Dec 31, 2024 | 53.58B | 1.12B | 2.14% |
| Dec 31, 2023 | 52.46B | 2.40B | 4.80% |
| Dec 31, 2022 | 50.06B | 9.59B | 23.71% |
| Dec 31, 2021 | 40.46B | -11.77B | -22.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hurum | 99.01B |
| GeneBioTech Co. ,Ltd | 90.79B |
| Korean Drug | 62.51B |
| ChoA Pharmaceutical Co., LTD. | 59.31B |
| WooGene B&G | 54.76B |
| Eagle Veterinary Technology Co.,Ltd | 43.32B |
| Union Korea Pharm | 33.83B |
| Daesung Microbiological Labs. | 25.99B |